<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0245">
 <element-citation publication-type="journal" id="h0245">
  <person-group person-group-type="author">
   <name>
    <surname>Xiao</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>Q.</given-names>
   </name>
  </person-group>
  <article-title>Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a phase II multicenter randomised controlled trial</article-title>
  <source>Age Ageing</source>
  <volume>46</volume>
  <year>2017</year>
  <fpage>767</fpage>
  <lpage>773</lpage>
  <pub-id pub-id-type="pmid">28419192</pub-id>
 </element-citation>
</ref>
